These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 34040244)

  • 1. The COVID vaccine pioneer behind southeast Asia's first mRNA shot.
    Mallapaty S
    Nature; 2021 Jun; 594(7862):163. PubMed ID: 34040244
    [No Abstract]   [Full Text] [Related]  

  • 2. The lightning-fast quest for COVID vaccines - and what it means for other diseases.
    Ball P
    Nature; 2021 Jan; 589(7840):16-18. PubMed ID: 33340018
    [No Abstract]   [Full Text] [Related]  

  • 3. The overlooked superpower of mRNA vaccines.
    Wadman M
    Science; 2021 Jul; 373(6554):479. PubMed ID: 34326217
    [No Abstract]   [Full Text] [Related]  

  • 4. Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.
    Normark J; Vikström L; Gwon YD; Persson IL; Edin A; Björsell T; Dernstedt A; Christ W; Tevell S; Evander M; Klingström J; Ahlm C; Forsell M
    N Engl J Med; 2021 Sep; 385(11):1049-1051. PubMed ID: 34260850
    [No Abstract]   [Full Text] [Related]  

  • 5. Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell's palsy.
    Soeiro T; Salvo F; Pariente A; Grandvuillemin A; Jonville-Béra AP; Micallef J
    Therapie; 2021; 76(4):365-367. PubMed ID: 33858693
    [No Abstract]   [Full Text] [Related]  

  • 6. Iran hopes to defeat COVID with home-grown crop of vaccines.
    Mallapaty S
    Nature; 2021 Aug; 596(7873):475. PubMed ID: 34404947
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthetic Messenger RNA-Based Vaccines: from Scorn to Hype.
    Pascolo S
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33572452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CureVac COVID vaccine let-down spotlights mRNA design challenges.
    Dolgin E
    Nature; 2021 Jun; 594(7864):483. PubMed ID: 34145413
    [No Abstract]   [Full Text] [Related]  

  • 9. What scientists do and don't know about the Oxford-AstraZeneca COVID vaccine.
    Mallapaty S; Callaway E
    Nature; 2021 Apr; 592(7852):15-17. PubMed ID: 33762708
    [No Abstract]   [Full Text] [Related]  

  • 10. COVID-19 vaccines: A race against time.
    Peiffer-Smadja N; Rozencwajg S; Kherabi Y; Yazdanpanah Y; Montravers P
    Anaesth Crit Care Pain Med; 2021 Apr; 40(2):100848. PubMed ID: 33774261
    [No Abstract]   [Full Text] [Related]  

  • 11. Mini Review Immunological Consequences of Immunization With COVID-19 mRNA Vaccines: Preliminary Results.
    Lombardi A; Bozzi G; Ungaro R; Villa S; Castelli V; Mangioni D; Muscatello A; Gori A; Bandera A
    Front Immunol; 2021; 12():657711. PubMed ID: 33777055
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunogenicity and Safety of COVID-19 mRNA Vaccine in STAT1 GOF Patients.
    Bloomfield M; Parackova Z; Hanzlikova J; Lastovicka J; Sediva A
    J Clin Immunol; 2022 Feb; 42(2):266-269. PubMed ID: 34718945
    [No Abstract]   [Full Text] [Related]  

  • 13. How COVID unlocked the power of RNA vaccines.
    Dolgin E
    Nature; 2021 Jan; 589(7841):189-191. PubMed ID: 33437061
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety of mRNA-Based Vaccines for SARS CoV-2.
    Barda B; Cerny A
    Chem Res Toxicol; 2021 Aug; 34(8):1823-1825. PubMed ID: 34009959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccines against COVID-19.
    Locht C
    Anaesth Crit Care Pain Med; 2020 Dec; 39(6):703-705. PubMed ID: 33096260
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine.
    Krammer F; Srivastava K; Alshammary H; Amoako AA; Awawda MH; Beach KF; Bermúdez-González MC; Bielak DA; Carreño JM; Chernet RL; Eaker LQ; Ferreri ED; Floda DL; Gleason CR; Hamburger JZ; Jiang K; Kleiner G; Jurczyszak D; Matthews JC; Mendez WA; Nabeel I; Mulder LCF; Raskin AJ; Russo KT; Salimbangon AT; Saksena M; Shin AS; Singh G; Sominsky LA; Stadlbauer D; Wajnberg A; Simon V
    N Engl J Med; 2021 Apr; 384(14):1372-1374. PubMed ID: 33691060
    [No Abstract]   [Full Text] [Related]  

  • 17. COVID vaccine makers brace for a variant worse than Delta.
    Waltz E
    Nature; 2021 Oct; 598(7882):552-553. PubMed ID: 34671153
    [No Abstract]   [Full Text] [Related]  

  • 18. The Century of mRNA Vaccines: COVID-19 Vaccines and Allergy.
    Ortega Rodríguez NR; Audícana Berasategui MT; de la Hoz Caballer B; Valero Santiago A
    J Investig Allergol Clin Immunol; 2021 Feb; 31(1):89-91. PubMed ID: 33393485
    [No Abstract]   [Full Text] [Related]  

  • 19. A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2.
    Huang Q; Ji K; Tian S; Wang F; Huang B; Tong Z; Tan S; Hao J; Wang Q; Tan W; Gao GF; Yan J
    Nat Commun; 2021 Feb; 12(1):776. PubMed ID: 33536425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against COVID-19 (CoviVac) in preclinical studies.
    Kozlovskaya LI; Piniaeva AN; Ignatyev GM; Gordeychuk IV; Volok VP; Rogova YV; Shishova AA; Kovpak AA; Ivin YY; Antonova LP; Mefyod KM; Prokosheva LS; Sibirkina AS; Tarasova YY; Bayurova EO; Gancharova OS; Illarionova VV; Glukhov GS; Sokolova OS; Shaitan KV; Moysenovich AM; Gulyaev SA; Gulyaeva TV; Moroz AV; Gmyl LV; Ipatova EG; Kirpichnikov MP; Egorov AM; Siniugina AA; Ishmukhametov AA
    Emerg Microbes Infect; 2021 Dec; 10(1):1790-1806. PubMed ID: 34427172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.